Alternatives to Cellbox Solutions

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered knowledge discovery for life sciences.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Revolutionizing genomic analysis with innovative sequencing technology.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Pioneering vision restoration therapies for severe retinal degenerations.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Wilbe provides flexible lab infrastructure and services for science startups.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Develops and distributes bioreactor technology for stem cell cultivation.

Platform designed to cut cell and gene therapy production costs.

AI-enabled technology for cell biology research and biopharma development.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

A leading incubator and venture builder in deep tech and life science.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

A biotech spin-out from the University of Edinburgh developing novel bioprocessing solutions.

Developing human microbiology models for drug discovery.

Empowering pharmaceutical researchers with advanced molecular understanding.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Enzyme-based technology to break down alcohol in the stomach.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A leading organization dedicated to curing and treating cystic fibrosis.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Developing novel immunotherapies and diagnostics for cancer.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.